NORWEGIAN MYCELIUM AS
Operating
Forskning og utvikling av bærekraftige materialer og nye kilder til
protein.
Ved bruk av mycel (rotstrukturen i sopp), skal Microlistic utvikle
bærekraftige materialer som er 100 % nedbrytbare i naturen samt
utvikle nye kilder til protein som kan brukes i mat og dyrefôr.
Organization
- CEO
- ID
Ingrid Dynna1980
- Chairman of the board
- MH
- Years since formation
- 6 years
- since Dec 2, 2020
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 10
Ownership
- Number of shares and share classes
- 1,784,313
- 2 share classes
- Total number of shareholders
- 33
- 23 companies, 10 persons
Financials
- Total operating income 2025
- 3,823,536
- NOK
- Annual total result 2025
- -18,296,878
- NOK
- Total equity 2025
- 18,423,561
- NOK
Last update: Sep 14, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
ID 1980 | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
MH | Chairman | - |
ID 1980 | Board Member | - |
DA | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - | |
| Accountant | - | |
| Auditor | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
AQ | - | 30.82 % indirectly |
DI 1980 | - | 25.22 % indirectly |
FG 1967 | - | 2.58 % indirectly |
| - | 1.87 % indirectly | |
DV 1947 | - | 1.23 % indirectly |
| - | 1.2 % indirectly | |
KM | - | 1.04 % indirectly |
Last update: Apr 15, 2026
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 550,000 | 30.82 % | |
| Ordinary shares | 450,000 | 25.22 % | |
| Preference shares | 129,307 | 7.25 % | |
| Preference shares | 100,656 | 5.64 % | |
| Ordinary shares | 89,386 | 5.01 % | |
| Preference shares | 76,560 | 4.29 % | |
| Ordinary shares | 55,606 | 3.12 % | |
| Ordinary shares | 55,606 | 3.12 % | |
| Ordinary shares | 33,455 | 1.87 % | |
| Ordinary shares | 27,749 | 1.56 % | |
| Ordinary shares | 27,452 | 1.54 % | |
| Ordinary shares | 21,396 | 1.2 % | |
| Preference shares | 20,400 | 1.14 % | |
| Ordinary shares | 13,966 | 0.78 % | |
| Ordinary shares | 13,966 | 0.78 % | |
| Ordinary shares | 13,966 | 0.78 % | |
| Ordinary shares | 13,902 | 0.78 % | |
| Ordinary shares | 13,902 | 0.78 % | |
| Ordinary shares | 11,779 | 0.66 % | |
| Ordinary shares | 10,079 | 0.56 % | |
| Ordinary shares | 9,007 | 0.5 % | |
| Ordinary shares | 7,595 | 0.43 % | |
| Ordinary shares | 6,306 | 0.35 % | |
| Ordinary shares | 5,889 | 0.33 % | |
| Ordinary shares | 4,448 | 0.25 % | |
| Ordinary shares | 3,492 | 0.2 % | |
| Preference shares | 3,409 | 0.19 % | |
BG | Ordinary shares | 3,396 | 0.19 % |
AM | Ordinary shares | 2,780 | 0.16 % |
| Ordinary shares | 2,500 | 0.14 % | |
| Ordinary shares | 2,500 | 0.14 % | |
| Ordinary shares | 2,462 | 0.14 % | |
| Ordinary shares | 1,396 | 0.08 % |
Shares owned by the NORWEGIAN MYCELIUM AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 2,500 | 0.14 % |
Last update: Sep 25, 2026
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 3,823,536 | 6,716,202 | 704,178 | 1,338,767 | 1,101,100 |
Annual Total Result | -18,296,878 | -10,128,076 | -9,342,275 | -4,501,844 | -1,211,568 |
Total assets | 22,044,175 | 10,579,940 | 6,906,562 | 10,674,533 | 1,859,155 |
Total liabilities | 3,620,614 | 3,928,845 | 1,729,981 | 871,189 | 478,602 |
Total equity | 18,423,561 | 6,651,095 | 5,176,580 | 9,803,344 | 1,380,553 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 3,823,536 | 6,716,202 | 704,178 | 1,338,767 | 1,101,100 |
Total operating costs | 22,323,351 | 16,879,154 | 10,020,071 | 5,816,809 | 2,305,228 |
Operating result | -18,499,815 | -10,162,952 | -9,315,893 | -4,478,042 | -1,204,128 |
Financial income/costs | 202,937 | 34,876 | -26,382 | -23,802 | -424 |
Profit before tax | -18,296,878 | -10,128,076 | -9,342,275 | -4,501,844 | -1,204,552 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 | 7,016 |
Annual Total Result | -18,296,878 | -10,128,076 | -9,342,275 | -4,501,844 | -1,211,568 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 2,759,475 | 3,921,152 | 2,166,974 | 1,537,743 | 0 |
Total current assets | 19,284,700 | 6,658,788 | 4,739,587 | 9,136,790 | 1,859,155 |
Total assets | 22,044,175 | 10,579,940 | 6,906,562 | 10,674,533 | 1,859,155 |
Short term debt | 2,620,614 | 3,928,845 | 1,729,981 | 871,189 | 478,602 |
Long term debt | 0 | 0 | 0 | 0 | 0 |
Total liabilities | 3,620,614 | 3,928,845 | 1,729,981 | 871,189 | 478,602 |
Contributed capital | 36,783,854 | 31,911,741 | 20,309,150 | 15,536,074 | 2,611,430 |
Retained earnings | -18,360,293 | -25,260,645 | -15,132,570 | -5,732,731 | -1,230,877 |
Total equity | 18,423,561 | 6,651,095 | 5,176,580 | 9,803,344 | 1,380,553 |
Total equity and liabilities | 22,044,175 | 10,579,940 | 6,906,562 | 10,674,533 | 1,859,155 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification